Viemed Healthcare Stock EBITDA
| VMD Stock | USD 8.67 0.11 1.29% |
Viemed Healthcare fundamentals help investors to digest information that contributes to Viemed Healthcare's financial success or failures. It also enables traders to predict the movement of Viemed Stock. The fundamental analysis module provides a way to measure Viemed Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Viemed Healthcare stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 36.7 M | 23.7 M |
Viemed | EBITDA |
Viemed Healthcare Company EBITDA Analysis
Viemed Healthcare's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Viemed Healthcare EBITDA | 36.71 M |
Most of Viemed Healthcare's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Viemed Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Viemed EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Viemed Healthcare is extremely important. It helps to project a fair market value of Viemed Stock properly, considering its historical fundamentals such as EBITDA. Since Viemed Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Viemed Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Viemed Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
Viemed EBITDA Historical Pattern
Today, most investors in Viemed Healthcare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Viemed Healthcare's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Viemed Healthcare ebitda as a starting point in their analysis.
Viemed Healthcare EBITDA |
| Timeline |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Viemed Ebitda
Ebitda |
|
According to the company disclosure, Viemed Healthcare reported earnings before interest,tax, depreciation and amortization of 36.71 M. This is 95.82% lower than that of the Health Care Equipment & Supplies sector and 94.29% lower than that of the Health Care industry. The ebitda for all United States stocks is 99.06% higher than that of the company.
Viemed EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Viemed Healthcare's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Viemed Healthcare could also be used in its relative valuation, which is a method of valuing Viemed Healthcare by comparing valuation metrics of similar companies.Viemed Healthcare is currently under evaluation in ebitda category among its peers.
Viemed Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Viemed Healthcare from analyzing Viemed Healthcare's financial statements. These drivers represent accounts that assess Viemed Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Viemed Healthcare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 233.8M | 300.6M | 206.1M | 292.2M | 301.1M | 316.1M | |
| Enterprise Value | 240.0M | 280.8M | 184.3M | 276.0M | 298.6M | 313.5M |
Viemed Healthcare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Viemed Healthcare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Viemed Healthcare's managers, analysts, and investors.Environmental | Governance | Social |
Viemed Healthcare Institutional Holders
Institutional Holdings refers to the ownership stake in Viemed Healthcare that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Viemed Healthcare's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Viemed Healthcare's value.| Shares | Awm Investment Company Inc | 2024-09-30 | 612.9 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 539 K | Tocqueville Asset Management L.p. | 2024-09-30 | 417.1 K | Raffles Associates Lp | 2024-09-30 | 402.7 K | Paradigm Capital Management, Inc. | 2024-06-30 | 400 K | Renaissance Technologies Corp | 2024-09-30 | 364.6 K | Divisadero Street Capital Management, Lp | 2024-09-30 | 349.8 K | Cove Street Capital, Llc | 2024-09-30 | 349.2 K | Bard Associates Inc | 2024-09-30 | 345.1 K | Thrivent Financial For Lutherans | 2024-09-30 | 3.4 M | Blackrock Inc | 2024-06-30 | 2.9 M |
Viemed Fundamentals
| Return On Equity | 0.0888 | ||||
| Return On Asset | 0.0686 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 333.49 M | ||||
| Shares Outstanding | 38.94 M | ||||
| Shares Owned By Insiders | 12.63 % | ||||
| Shares Owned By Institutions | 66.67 % | ||||
| Number Of Shares Shorted | 291.18 K | ||||
| Price To Earning | 29.88 X | ||||
| Price To Book | 2.70 X | ||||
| Price To Sales | 1.58 X | ||||
| Revenue | 183.01 M | ||||
| Gross Profit | 84.68 M | ||||
| EBITDA | 36.71 M | ||||
| Net Income | 10.24 M | ||||
| Cash And Equivalents | 21.92 M | ||||
| Cash Per Share | 0.57 X | ||||
| Total Debt | 10.32 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 2.34 X | ||||
| Book Value Per Share | 3.21 X | ||||
| Cash Flow From Operations | 45.21 M | ||||
| Short Ratio | 1.37 X | ||||
| Earnings Per Share | 0.25 X | ||||
| Target Price | 12.27 | ||||
| Number Of Employees | 1.14 K | ||||
| Beta | 1.44 | ||||
| Market Capitalization | 337.58 M | ||||
| Total Asset | 154.9 M | ||||
| Retained Earnings | 79.5 M | ||||
| Working Capital | 6.24 M | ||||
| Net Asset | 154.9 M |
About Viemed Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Viemed Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Viemed Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Viemed Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Viemed Healthcare is a strong investment it is important to analyze Viemed Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Viemed Healthcare's future performance. For an informed investment choice regarding Viemed Stock, refer to the following important reports:Check out Viemed Healthcare Piotroski F Score and Viemed Healthcare Altman Z Score analysis. For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viemed Healthcare. If investors know Viemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viemed Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.425 | Earnings Share 0.25 | Revenue Per Share 5.534 | Quarterly Revenue Growth 0.174 | Return On Assets 0.0686 |
The market value of Viemed Healthcare is measured differently than its book value, which is the value of Viemed that is recorded on the company's balance sheet. Investors also form their own opinion of Viemed Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Viemed Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viemed Healthcare's market value can be influenced by many factors that don't directly affect Viemed Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viemed Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viemed Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viemed Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.